Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ALX ONCOLOGY HOLDINGS INC.

(ALXO)
  Report
Delayed Nasdaq  -  04:00 2022-09-28 pm EDT
9.940 USD   +4.85%
09/28Alx Oncology : Corporate Presentation
PU
09/21ALX Oncology to Participate in the Cantor Oncology, Hematology & HemeOnc Conference
GL
09/21ALX Oncology to Participate in the Cantor Oncology, Hematology & HemeOnc Conference
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on ALX ONCOLOGY HOLDINGS INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) ALX ONCOLOGY HOLDINGS INC.
Analyst Recommendations on ALX ONCOLOGY HOLDINGS INC.
08/26UBS Adjusts ALX Oncology Price Target to $31 From $37, Maintains Buy Rating
MT
08/09Cantor Fitzgerald Adjusts ALX Oncology Holdings' Price Target to $32 from $60, Maintains O..
MT
08/09Credit Suisse Lowers ALX Oncology Holdings' PT to $38 from $43, Notes Increased Discount R..
MT
06/06Stifel Adjusts Price Target on ALX Oncology Holdings to $16 From $35, Reiterates Buy Ratin..
MT
05/19Piper Sandler Adjusts Price Target on ALX Oncology Holdings to $48 From $70, Reiterates Ov..
MT
03/14Cantor Fitzgerald Adjusts Price Target for ALX Oncology to $60 From $103, Maintains Overwe..
MT
03/01Stifel Adjusts ALX Oncology Holdings' Price Target to $36 from $60, Maintains Buy Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 9,94 $
Average target price 38,13 $
Spread / Average Target 284%
High Price Target 80,00 $
Spread / Highest target 705%
Low Price Target 12,00 $
Spread / Lowest Target 20,7%
Consensus detail
Consensus revision (last 18 months)